The Safety and Immunogenicity of GTU(®)MultiHIV DNA Vaccine Delivered by Transcutaneous and Intramuscular Injection With or Without Electroporation in HIV-1 Positive Subjects on Suppressive ART

Previous studies have shown targeting different tissues via the transcutaneous (TC) and intramuscular injection (IM) with or without electroporation (EP) has the potential to trigger immune responses to DNA vaccination. The CUTHIVTHER 001 Phase I/II randomized controlled clinical trial was designed...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Front Immunol
Główni autorzy: Haidari, G., Day, Suzanne, Wood, M., Ridgers, H., Cope, Alethea V., Fleck, Sue, Yan, Celine, Reijonen, Kalevi, Hannaman, Drew, Spentzou, Aggeliki, Hayes, Peter, Vogt, A., Combadiere, Behazine, Cook, Adrian, McCormack, Sheena, Shattock, Robin J.
Format: Artigo
Język:Inglês
Wydane: Frontiers Media S.A. 2019
Hasła przedmiotowe:
Immunology
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6923267/
https://ncbi.nlm.nih.gov/pubmed/31921170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.02911
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy